Todd Bazemore - 22 Oct 2025 Form 4 Insider Report for KALA BIO, Inc. (KALA)

Reporting relationship: Director
Issuer ticker: KALA
Reported as of: 22 Oct 2025
Net transaction value: -$39,647
SEC form: 4
Accepted by SEC: 24 Oct 2025, 20:00:09 UTC
Prior SEC filing: 02 Sep 2025
Source filing: View source filing
Reporting owner signature: /s/ Mary Reumuth, Attorney-in-Fact

Key filing fact

Todd Bazemore filed Form 4 for KALA BIO, Inc. (KALA) on 24 Oct 2025.

Key facts

This page summarizes Todd Bazemore's Form 4 filing for KALA BIO, Inc. (KALA).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 24 Oct 2025, 20:00.

Change

Previous filing in this sequence was filed on 02 Sep 2025.
Current net transaction value: -$39,647.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001605767 Primary reporting owner

Bazemore Todd

Relationship: Director
Address: C/O KALA BIO, INC., 1167 MASSACHUSETTS AVENUE, ARLINGTON
Signature: /s/ Mary Reumuth, Attorney-in-Fact
Signature date: 24 Oct 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

KALA transaction

Common Stock

Sale

Transaction value: $39,647
Shares: -47,768
Change %: -57%
Price: $0.8300
Shares after: 35,932
Date: 22 Oct 2025
Ownership: Direct
Footnotes: F1, F2

KALA holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1
Date: 22 Oct 2025
Ownership: By son

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.82 to $0.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.

Footnote F2

Includes 35,732 unvested RSUs.